Royal Bank of Canada Forecasts Strong Price Appreciation for Axsome Therapeutics (NASDAQ:AXSM) Stock
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price boosted by Royal Bank of Canada from $143.00 to $192.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price suggests a potential upside of 48.66% […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price boosted by Royal Bank of Canada from $143.00 to $192.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price suggests a potential upside of 48.66% […]
